Related Experiment Videos

The murine PKR tumor suppressor gene is rearranged in a lymphocytic leukemia

N Abraham1, M L Jaramillo, P I Duncan

  • 1Ottawa Regional Cancer Center Research Laborotories, 501 Smyth Road, Ottawa, Ontario, K1H 8L6, Canada.

Experimental Cell Research
|November 10, 1998
PubMed

Insights

The double-stranded RNA-dependent kinase (PKR) plays a role in cellular growth. A mutated, inactive form of PKR was identified in a murine leukemia cell line, suggesting reduced PKR activity in tumors.

Area of Science:

  • Molecular biology
  • Virology
  • Cancer research

Background:

  • The double-stranded RNA-dependent kinase (PKR) is an interferon-inducible enzyme crucial for antiviral defense.
  • PKR is also implicated in regulating normal cellular growth.
  • While viral inactivation of PKR is known, its inactivation in tumors remains uncharacterized.

Purpose of the Study:

  • To investigate the role of PKR in cellular growth regulation and tumor development.
  • To identify potential mechanisms of PKR inactivation in cancer.
  • To characterize the murine homolog of PKR and its potential mutations in leukemia.

Main Methods:

  • Gene cloning and sequencing
  • Analysis of mutated PKR transcripts
  • Biochemical assays to assess kinase activity and dsRNA binding

Main Results:

  • The Tik gene, the murine homolog of PKR (mPKR), was identified.
  • A rearranged mPKR allele was found in a murine lymphocytic leukemia cell line.
  • A mutated mPKR transcript encoded a catalytically inactive but dsRNA-binding and dimerizing polypeptide.

Conclusions:

  • Reduced PKR activity may occur in tumors due to mutations.
  • The identified mutated mPKR, while not dominant-negative, contributes to decreased PKR function in leukemia cells.
  • This finding highlights a potential role for PKR dysregulation in cancer development.

Related Concept Videos